In this episode, Peter M. Kovacs speaks with Roswitha Verwer and Dr. Muskaan Bhan, the founders of YON E Health, about transforming personal trauma into global innovation. They discuss the journey from idea to clinical-grade Femtech, data ethics, diversity in research, and why women’s health is the next major frontier for investors and operators alike.
Chapters
00:00 Introduction and context
01:15 How Roswitha and Muskaan met
04:30 The personal story behind YON E Health
08:10 What pH and temperature tell us about women’s health
12:25 Building a medical device from concept to clinical validation
18:40 Why diversity in clinical data matters
23:00 Regulatory roadmap and CE/FDA pathway
27:30 Investment challenges for female founders
33:00 Data privacy, consent, and trust
39:45 Culture, education, and global adoption
45:20 Team building and advisory governance
52:10 The future of Femtech and Peter’s reflections
If you are investing in healthcare or building within Femtech, watch this discussion to understand why precision, transparency, and inclusion are the new performance metrics.
Subscribe to Clinical Capital Conversations for unfiltered discussions at the crossroads of science and capital.
